Cargando…

Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors

BACKGROUND: Lymph node metastasis of rectal neuroendocrine tumors (RNETs) predicts poor prognosis. However, the assessment of lymph node metastasis remains a challenge. It has been reported that 68Ga-DOTANOC and 18F-FDG PET-CT scans could be employed in the work-up of rectal neuroendocrine tumors (R...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhihao, Wang, Zhixiong, Zhang, Bing, Wu, Yanzhang, Li, Guanghua, Wang, Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440966/
https://www.ncbi.nlm.nih.gov/pubmed/34539577
http://dx.doi.org/10.3389/fendo.2021.727327
_version_ 1783752778626105344
author Zhou, Zhihao
Wang, Zhixiong
Zhang, Bing
Wu, Yanzhang
Li, Guanghua
Wang, Zhao
author_facet Zhou, Zhihao
Wang, Zhixiong
Zhang, Bing
Wu, Yanzhang
Li, Guanghua
Wang, Zhao
author_sort Zhou, Zhihao
collection PubMed
description BACKGROUND: Lymph node metastasis of rectal neuroendocrine tumors (RNETs) predicts poor prognosis. However, the assessment of lymph node metastasis remains a challenge. It has been reported that 68Ga-DOTANOC and 18F-FDG PET-CT scans could be employed in the work-up of rectal neuroendocrine tumors (RNETs). This study aimed to assess both tracers’ ability to identify primary tumors and lymph node (LN) metastasis in RNETs. METHODS: A total of 537 patients with RNETs were enrolled from January 2014 to January 2021. Both 68Ga-DOTANOC and 18F-FDG PET-CT scans were used to evaluate primary tumors and LN group metastasis. PET images were evaluated through visual and semiquantitative assessment. Receiver Operating Characteristics (ROC) curve analysis was used to investigate the performance of SUVmax of 68Ga-DOTANOC and 18F-FDG PET in predicting LN group metastasis. RESULTS: Fifty-two patients with preoperative 68Ga-DOTANOC with 18F-FDG PET-CT scans underwent endoscopic biopsy or dissection of the primary tumor, while 11 patients underwent rectal surgery together with regional LN dissection. For primary tumors, 68Ga-DOTANOC had a sensitivity of 89.58% and a positive predictive value (PPV) of 95.56% through visual assessment, while 18F-FDG PET-CT showed 77.08% sensitivity and 97.37% PPV. For the prediction of LN group metastasis, 68Ga-DOTANOC PET-CT had 77.78% sensitivity and 91.67% specificity, while 18F-FDG PET-CT had 38.89% sensitivity and 100% specificity according to visual assessment. The area under the ROC curves (AUC) for 68Ga-DOTANOC PET/CT was 0.852 (95%CI:0.723-0.981) with an optimal SUVmax cut-off value of 2.25, while the AUC for 18F-FDG PET were 0.664 (95%CI:0.415-0.799) with an optimal SUVmax cut-off value of 1.05. CONCLUSIONS: This study showed that 68Ga-DOTANOC PET-CT was a promising tool for detecting LN metastasis in RNETs with high sensitivity and specificity in visual assessment and semiquantitative assessment, which was better than 18F-FDG PET-CT.
format Online
Article
Text
id pubmed-8440966
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84409662021-09-16 Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors Zhou, Zhihao Wang, Zhixiong Zhang, Bing Wu, Yanzhang Li, Guanghua Wang, Zhao Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Lymph node metastasis of rectal neuroendocrine tumors (RNETs) predicts poor prognosis. However, the assessment of lymph node metastasis remains a challenge. It has been reported that 68Ga-DOTANOC and 18F-FDG PET-CT scans could be employed in the work-up of rectal neuroendocrine tumors (RNETs). This study aimed to assess both tracers’ ability to identify primary tumors and lymph node (LN) metastasis in RNETs. METHODS: A total of 537 patients with RNETs were enrolled from January 2014 to January 2021. Both 68Ga-DOTANOC and 18F-FDG PET-CT scans were used to evaluate primary tumors and LN group metastasis. PET images were evaluated through visual and semiquantitative assessment. Receiver Operating Characteristics (ROC) curve analysis was used to investigate the performance of SUVmax of 68Ga-DOTANOC and 18F-FDG PET in predicting LN group metastasis. RESULTS: Fifty-two patients with preoperative 68Ga-DOTANOC with 18F-FDG PET-CT scans underwent endoscopic biopsy or dissection of the primary tumor, while 11 patients underwent rectal surgery together with regional LN dissection. For primary tumors, 68Ga-DOTANOC had a sensitivity of 89.58% and a positive predictive value (PPV) of 95.56% through visual assessment, while 18F-FDG PET-CT showed 77.08% sensitivity and 97.37% PPV. For the prediction of LN group metastasis, 68Ga-DOTANOC PET-CT had 77.78% sensitivity and 91.67% specificity, while 18F-FDG PET-CT had 38.89% sensitivity and 100% specificity according to visual assessment. The area under the ROC curves (AUC) for 68Ga-DOTANOC PET/CT was 0.852 (95%CI:0.723-0.981) with an optimal SUVmax cut-off value of 2.25, while the AUC for 18F-FDG PET were 0.664 (95%CI:0.415-0.799) with an optimal SUVmax cut-off value of 1.05. CONCLUSIONS: This study showed that 68Ga-DOTANOC PET-CT was a promising tool for detecting LN metastasis in RNETs with high sensitivity and specificity in visual assessment and semiquantitative assessment, which was better than 18F-FDG PET-CT. Frontiers Media S.A. 2021-09-01 /pmc/articles/PMC8440966/ /pubmed/34539577 http://dx.doi.org/10.3389/fendo.2021.727327 Text en Copyright © 2021 Zhou, Wang, Zhang, Wu, Li and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Zhou, Zhihao
Wang, Zhixiong
Zhang, Bing
Wu, Yanzhang
Li, Guanghua
Wang, Zhao
Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors
title Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors
title_full Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors
title_fullStr Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors
title_full_unstemmed Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors
title_short Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors
title_sort comparison of 68ga-dotanoc and 18f-fdg pet-ct scans in the evaluation of primary tumors and lymph node metastasis in patients with rectal neuroendocrine tumors
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440966/
https://www.ncbi.nlm.nih.gov/pubmed/34539577
http://dx.doi.org/10.3389/fendo.2021.727327
work_keys_str_mv AT zhouzhihao comparisonof68gadotanocand18ffdgpetctscansintheevaluationofprimarytumorsandlymphnodemetastasisinpatientswithrectalneuroendocrinetumors
AT wangzhixiong comparisonof68gadotanocand18ffdgpetctscansintheevaluationofprimarytumorsandlymphnodemetastasisinpatientswithrectalneuroendocrinetumors
AT zhangbing comparisonof68gadotanocand18ffdgpetctscansintheevaluationofprimarytumorsandlymphnodemetastasisinpatientswithrectalneuroendocrinetumors
AT wuyanzhang comparisonof68gadotanocand18ffdgpetctscansintheevaluationofprimarytumorsandlymphnodemetastasisinpatientswithrectalneuroendocrinetumors
AT liguanghua comparisonof68gadotanocand18ffdgpetctscansintheevaluationofprimarytumorsandlymphnodemetastasisinpatientswithrectalneuroendocrinetumors
AT wangzhao comparisonof68gadotanocand18ffdgpetctscansintheevaluationofprimarytumorsandlymphnodemetastasisinpatientswithrectalneuroendocrinetumors